Thursday, March 8, 2012
Canadian researchers have found that injecting ganglioside
GM1, a naturally occurring lipid, into the brains of mice
with Huntington's disease improves motor function and slows disease
progression.1 The team is in talks with an undisclosed company to
license the findings.
Osherovich, L. SciBX 5(10); doi:10.1038/scibx.2012.243
Published online March 8, 2012
1. Di Pardo, A. et al.
Proc. Natl. Acad. Sci. USA; published online Feb. 13, 2012;
Contact: Simonetta Sipione, University of Alberta, Edmonton, Alberta,
2. Maglione, V. et al.
J. Neurosci. 30, 4072-4080 (2010)
3. Denny, C.A. et al.
J. Neurochem. 115, 748-758 (2010)
4. Schneider, J.S. et
al. Parkinson's disease: mechanisms of degeneration and
treatment I. Presented at the Society for Neuroscience
annual meeting, Nov. 12-16, 2011
AND INSTITUTIONS MENTIONED
Gladstone Institute of Neurological Disease,
San Francisco, Calif.
H. Lundbeck A/S (CSE:LUN), Copenhagen, Denmark
LZ Therapeutics Inc., Malvern, Pa.
NeuroSearch A/S (CSE:NEUR), Ballerup, Denmark
Society for Neuroscience, Washington, D.C.
Thomas Jefferson University, Philadelphia, Pa.
University of Alberta, Edmonton, Alberta, Canada
University of California, San Francisco, Calif.